BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
Go back to BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform| (NASDAQ: BHST) | Delayed: 2.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $ | |||
| Open | $2.18 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.18 | EPS | $ | |||
| Volume | 6 | |||||
